Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi MSCI World Health Care UCITS ETF USD Acc
HLTG · LU0533033311 · class UCITS ETF USD Acc · USD · domicile Luxembourg
Equity · Global · Health careSFDR art. 6
Index tracked: MSCI Daily TR World Net Health Care USD
- TER
- 0.30%+ trans. 0.00%
- Fund size
- 90 m EUR
- Tracking difference
- −0.25%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 19 Aug 2010 · costs from the KID as of 2 Sept 2026 · 50 securities held · 5 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 7 Aug 2026
The Fund is an index-tracking UCITS passively managed. The investment objective of the Fund is to track both the upward and downward evolution of the MSCI WORLD HEALTH CARE Net Total Return Index (net dividends reinvested) ("Benchmark Index"), denominated in US Dollars, representative of healthcare companies from the Developed World markets, while minimizing the volatility of the difference between the return of the Fund and the return of the Benchmark Index (the Tracking Error"). The anticipated level of tracking error in normal market conditions is…
Performance since series start (in euro) — base 100
2 Oct 2012 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +17.1% |
| 3 years | +15.6% |
| 5 years | +22.6% |
| 10 years | +118.8% |
| Since series start | +321.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 14.76% | 12.91% | 13.32% |
| Max drawdown | −10.51% | −17.76% | −17.76% |
| Sharpe | 0.94 | 0.38 | 0.16 |
| Sortino | 1.54 | 0.55 | 0.22 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · HLTG · LU05330333111
RebalixHLTG · LU0533033311 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +14.80% | +14.83% | −0.03% |
| 2024 | +0.80% | +1.13% | −0.33% |
| 2023 | +3.37% | +3.76% | −0.39% |
| 2022 | −5.71% | −5.41% | −0.29% |
| 2021 | +19.45% | +19.80% | −0.35% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 50 securities · top-10 weight = 57.1%
| Top holdings | Weight |
|---|---|
| 8.2% | |
| 8.1% | |
| 7.7% | |
| 5.9% | |
| 5.3% | |
| 4.6% | |
| 4.5% | |
| 4.4% | |
| 4.3% | |
| 4.2% |
Listing venues
ESMA register (FIRDS) and official exchange lists
7H60 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 6 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU0533033311
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU0533033311
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · HLTG · LU05330333112